Patient
SITE015-0030
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE015 (POL) (Dr. Ito)
consented 2025-09-28
Adverse events
2
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 2
mild
assessed
2026-03-14
Grade 1 Stomatitis — outcome: RECOVERED/RESOLVED; onset 2022-09-07 (study day 154); relationship: NOT RELATED
mild
assessed
2026-02-12
Grade 1 Dyspnoea — outcome: RECOVERED/RESOLVED; onset 2022-08-08 (study day 124); relationship: not assessed
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.